Safinamide tablets’ marketing status, approval information and patient access information in China

Safinamide tablets (Safinamide) are an auxiliary drug used to treat Parkinson's disease. It can improve patients' motor function fluctuations and is especially suitable for patients whose levodopa treatment is insufficient. At present, safinamide has been approved for marketing in China and has become an optional treatment drug for patients with Parkinson's disease, but it is not yet included in the scope of medical insurance, so patients need to purchase it at their own expense. The domestic market specification is 30 tablets per box, and the price per box is approximately 1,600 multiple RMB.

Domestic patients mainly obtain safinamide tablets through regular hospital pharmacies and authorized drug retail channels. When purchasing, you must have a prescription from a doctor to ensure clear indications and compliance with medication safety regulations. Hospital pharmacies usually provide relevant medication guidance, including dosage selection, medication time, and precautions for combined use with other Parkinson's disease medications, to help patients use medications rationally.

In overseas markets, safinamide tablets are also available as original drugs and generic drugs. The specifications of the original drug in the European market are 100 tablets per box, and the price is about 5,000 yuan, while there are generic drugs in the Indian market, the price is about 400 yuan, which is more affordable. Generic drugs are basically the same active ingredients as original drugs, which can provide patients with more economical choices while ensuring efficacy.

When using safinamide tablets, patients should strictly follow the doctor's instructions and purchase drugs through formal channels, and avoid purchasing through informal channels or cross-border purchases to ensure drug quality and medication safety. At the same time, patients should also pay attention to the side effects of the drug and interactions with other drugs so that the treatment plan can be adjusted in a timely manner to maximize the therapeutic effect.

Keyword tags:

Shafinamide tablets, launched in China, approval information, access methods, medical insurance policy, original drug, generic drug, price comparison

Reference materials:https://www.drugs.com/monograph/safinamide.html